Gland Pharma Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Gland Pharma kazanç ve gelirin sırasıyla yıllık 25.8% ve 11% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 25.9% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11% olacağı tahmin edilmektedir.

Anahtar bilgiler

25.8%

Kazanç büyüme oranı

25.9%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi18.4%
Gelir büyüme oranı11.0%
Gelecekteki özkaynak getirisi11.0%
Analist kapsamı

Good

Son güncelleme05 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Nov 07
Gland Pharma Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Gland Pharma Limited (NSE:GLAND) Shares Could Be 23% Above Their Intrinsic Value Estimate

Oct 26
Gland Pharma Limited (NSE:GLAND) Shares Could Be 23% Above Their Intrinsic Value Estimate

Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Oct 01
Gland Pharma (NSE:GLAND) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Sep 05
Investors Still Waiting For A Pull Back In Gland Pharma Limited (NSE:GLAND)

Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 09
Gland Pharma Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Jun 22
Does Gland Pharma (NSE:GLAND) Have A Healthy Balance Sheet?

Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

May 25
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Kazanç ve Gelir Büyüme Tahminleri

NSEI:GLAND - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/202776,95513,1328,38610,3379
3/31/202668,95211,0357,2709,27310
3/31/202561,1548,1645,4296,80710
9/30/202459,1056,9168,19512,187N/A
6/30/202458,5777,221N/AN/AN/A
3/31/202456,6477,7255,9859,968N/A
12/31/202349,1236,587N/AN/AN/A
9/30/202343,0546,9888323,901N/A
6/30/202339,7647,460N/AN/AN/A
3/31/202336,2467,8101,4083,640N/A
12/31/202239,4269,883N/AN/AN/A
9/30/202240,67610,2936,7479,508N/A
6/30/202241,03710,902N/AN/AN/A
3/31/202244,00712,1172,6877,908N/A
12/31/202141,85411,862N/AN/AN/A
9/30/202139,81511,1723284,688N/A
6/30/202137,32610,340N/AN/AN/A
3/31/202134,6299,9703,7626,049N/A
12/31/202032,1049,313N/AN/AN/A
6/30/202028,4309,0277,0259,058N/A
3/31/202026,3327,7295,0637,009N/A
3/31/201920,4424,5194951,853N/A
3/31/201816,1993,211N/A2,021N/A
3/31/201714,7924,137N/A4,765N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: GLAND 'nin tahmini kazanç büyümesi (yıllık 25.8% ) tasarruf oranının ( 6.7% ) üzerindedir.

Kazançlar ve Piyasa: GLAND şirketinin kazançlarının (yıllık 25.8% ) Indian pazarından (yıllık 17.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: GLAND şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: GLAND şirketinin gelirinin (yıllık 11% ) Indian pazarından (yıllık 10.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: GLAND şirketinin gelirinin (yıllık 11% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: GLAND 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11 %).


Büyüyen şirketleri keşfedin